Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMMC.L Regulatory News (MMC)

  • There is currently no data for MMC

Directorate Change

17 Nov 2016 07:00

RNS Number : 4034P
Management Consulting Group PLC
17 November 2016
 

17 November 2016

 

 

Management Consulting Group PLC (the "Company" or "MCG")

 

Directorate Change

 

Management Consulting Group PLC announces that following the successful completion of the sale of the remaining Kurt Salmon business on 2 November 2016, Chris Povey, Group Finance Director, has decided to step down. Chris now wishes to pursue other opportunities, but has agreed to remain with the Group for an interim period whilst a suitable replacement is found. He will cease to be on the Board with immediate effect.

Nick Stagg, Chief Executive of MCG said:

"I would like to thank Chris for his considerable contribution to the Group. As Group Finance Director, he has been instrumental in helping to deliver significant change over the last few years culminating in the sale of Kurt Salmon. The Group is now focused on a single brand, Alexander Proudfoot, and our strategy is to develop this into a profitable and valuable business. Chris is a valued colleague and we wish him well for the future."

 

For further information please contact:

 

Management Consulting Group PLC

Nick Stagg

Chief Executive

020 7710 5000

Chris Povey

Finance Director

020 7710 5000

FTI Consulting

Ben Atwell

0203 727 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMMMMGNGGVZG
Date   Source Headline
20th Jul 20184:40 pmRNSSecond Price Monitoring Extn
20th Jul 20184:35 pmRNSPrice Monitoring Extension
18th Jul 201812:28 pmRNSDirectorate Change
18th Jul 201812:26 pmRNSGeneral Meeting and Placing and Open Offer Results
10th Jul 20189:01 amRNSUpdate on the Kurt Salmon escrow funds
2nd Jul 20189:50 amRNSResult of AGM
29th Jun 20181:06 pmRNSPublication of prospectus and notice of meeting
29th Jun 20187:00 amRNSProposed Placing and Open Offer
4th Jun 20186:18 pmRNSHolding(s) in Company
29th May 20187:00 amRNSUpdate on the disposal of Brazil business
10th May 20187:00 amRNSDirectorate Change
4th May 20187:00 amRNSDisposal of Brazil business
1st May 20187:00 amRNSFinal Results
27th Apr 20189:16 amRNSUpdate on escrow funds
23rd Apr 20183:02 pmRNSTrading statement and update on escrow funds
3rd Nov 20177:00 amRNSTrading Statement
18th Aug 20177:00 amRNSHalf-year Report
2nd Aug 20175:02 pmRNSHolding(s) in Company
6th Jun 20171:49 pmRNSDirector Declaration
31st May 201712:12 pmRNSDirectorate Change
30th May 201712:00 pmRNSResult of AGM
12th May 20174:57 pmRNSHolding(s) in Company
21st Apr 20174:06 pmRNSHolding(s) in Company
5th Apr 20179:16 amRNSHolding(s) in Company
29th Mar 20173:28 pmRNSHolding(s) in Company
15th Mar 20177:00 amRNSFinal Results
13th Mar 201712:34 pmRNSHolding(s) in Company
10th Mar 201712:32 pmRNSAppointment of Non-Executive Director
10th Mar 201710:27 amRNSHolding(s) in Company
7th Mar 20173:57 pmRNSHolding(s) in Company
23rd Jan 20173:47 pmRNSHolding(s) in Company
23rd Jan 20173:46 pmRNSHolding(s) in Company
20th Jan 20174:40 pmRNSSecond Price Monitoring Extn
20th Jan 20174:35 pmRNSPrice Monitoring Extension
12th Jan 201712:23 pmRNSHolding(s) in Company
9th Jan 20174:35 pmRNSPrice Monitoring Extension
6th Jan 20174:40 pmRNSSecond Price Monitoring Extn
6th Jan 20174:35 pmRNSPrice Monitoring Extension
22nd Dec 201611:54 amRNSDirector/PDMR Shareholding
19th Dec 20164:31 pmRNSHolding(s) in Company
15th Dec 20167:00 amRNSDirectorate Change
12th Dec 20168:00 amRNSHolding(s) in Company
7th Dec 20164:16 pmRNSReduction of Capital and Return of Capital update
2nd Dec 20167:00 amRNSReduction of Capital and Return of Capital update
30th Nov 20164:10 pmRNSTotal Voting Rights
25th Nov 20164:22 pmRNSHolding(s) in Company - Replacement
25th Nov 20163:30 pmRNSHolding(s) in Company
25th Nov 20163:23 pmRNSHolding(s) in Company
17th Nov 20167:00 amRNSDirectorate Change
15th Nov 201611:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.